Sustained Increases in Cardiomyocyte Protein O-Linked β-N-Acetylglucosamine Levels Lead to Cardiac Hypertrophy and

Chae-Myeong Ha1, Sayan Bakshi1, Manoja K Brahma1

  • 1Division of Molecular and Cellular Pathology, Department of Pathology University of Alabama at Birmingham Birmingham AL.

Insights

Sustained protein O-GlcNAcylation in heart cells initially reduces metabolic pathways but leads to cardiac remodeling and diastolic dysfunction over time. This study reveals adaptive vs. maladaptive responses to O-GlcNAcylation in the heart.

Area of Science:

  • Cardiovascular Disease Research
  • Metabolic Regulation
  • Posttranslational Modifications

Background:

  • Metabolic diseases and lifestyle factors significantly impact cardiovascular disease (CVD) pathogenesis.
  • Posttranslational modifications, such as O-linked β-N-acetylglucosamine (O-GlcNAcylation), play a role in physiological and pathological adaptations.
  • O-GlcNAcylation is implicated in the molecular mechanisms underlying cardiac function and dysfunction.

Purpose of the Study:

  • To investigate the hypothesis that sustained protein O-GlcNAcylation in cardiomyocytes contributes to cardiac adaptations.
  • To determine how O-GlcNAcylation progression leads from adaptation to pathophysiology.
  • To explore the differential responses of cardiac metabolism and function to increased O-GlcNAcylation.

Main Methods:

  • Utilized a cardiomyocyte-specific inducible transgenic mouse model overexpressing dominant-negative O-GlcNAcase (dnOGA).
  • Examined effects of 2-week and 24-week dnOGA overexpression on cardiac structure and function.
  • Conducted mRNA-sequencing to analyze gene expression changes related to metabolism and cardiovascular disease.

Main Results:

  • 24-week dnOGA overexpression led to a 1.8-fold increase in protein O-GlcNAcylation.
  • Cardiac hypertrophy, mitochondrial dysfunction, fibrosis, and diastolic dysfunction were observed after 24 weeks.
  • Systolic function was maintained, but gene expression showed reduced mitochondrial oxidative phosphorylation, fatty acid/glucose metabolism, and antioxidant pathways.

Conclusions:

  • Moderate increases in cardiomyocyte O-GlcNAcylation induce an initial reduction in metabolic pathways, followed by cardiac remodeling.
  • The mouse model exhibited diastolic dysfunction, consistent with heart failure with preserved ejection fraction (HFpEF).
  • Findings offer insights into adaptive and maladaptive responses to elevated O-GlcNAcylation in the heart.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
14
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
9
Proteoglycans01:05

Proteoglycans

Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
3.9K
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
611
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11